Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of medical sciences, 88, 10th floor, Italia Str., Keshavarz Blv, Tehran, Iran.
Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Mol Neurobiol. 2017 Sep;54(7):4963-4972. doi: 10.1007/s12035-016-0030-0. Epub 2016 Aug 13.
Cerebral palsy (CP) is a neuromuscular disease due to injury in the infant's brain. The CP disorder causes many neurologic dysfunctions in the patient. Various treatment methods have been used for the management of CP disorder. However, there has been no absolute cure for this condition. Furthermore, some of the procedures which are currently used for relief of symptoms in CP cause discomfort or side effects in the patient. Recently, stem cell therapy has attracted a huge interest as a new therapeutic method for treatment of CP. Several investigations in animal and human with CP have demonstrated positive potential of stem cell transplantation for the treatment of CP disorder. The ultimate goal of this therapeutic method is to harness the regenerative capacity of the stem cells causing a formation of new tissues to replace the damaged tissue. During the recent years, there have been many investigations on stem cell therapy. However, there are still many unclear issues regarding this method and high effort is needed to create a technology as a perfect treatment. This review will discuss the scientific background of stem cell therapy for cerebral palsy including evidences from current clinical trials.
脑性瘫痪(CP)是一种由婴儿大脑损伤引起的神经肌肉疾病。CP 障碍会导致患者出现许多神经功能障碍。目前已经有多种治疗方法用于 CP 障碍的管理。然而,这种疾病还没有绝对的治愈方法。此外,目前用于缓解 CP 症状的一些程序会给患者带来不适或副作用。最近,干细胞治疗作为一种治疗 CP 的新疗法引起了极大的兴趣。一些 CP 动物和人类的研究表明,干细胞移植对 CP 障碍的治疗具有积极的潜力。这种治疗方法的最终目标是利用干细胞的再生能力,形成新的组织来替代受损的组织。近年来,对干细胞治疗进行了许多研究。然而,这种方法仍有许多不清楚的问题,需要付出巨大的努力来创造一种完美的治疗技术。这篇综述将讨论干细胞治疗脑性瘫痪的科学背景,包括当前临床试验的证据。